2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) NU100, Placebo, rhIFN beta-1b - Relapsing Remitting Multiple Sclerosis | Phase 3 | Unknown | Nuron Biotech Inc. | 500 | 2011-10-01 | 2013-09-23 |
| A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis Simvastatin - Relapsing Remitting Multiple Sclerosis | Phase 3 | Unknown | Alabama Neurology Associates, PC | 30 | 2005-10-01 | 2005-12-07 |
Multiple Sclerosis, Relapsing-Remitting (2)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Multiple Sclerosis (2) · Nervous System Diseases (2)
Simvastatin (1)
Alabama Neurology Associates, PC (1) · Nuron Biotech Inc. (1)
Belarus (1) · Bulgaria (1) · Croatia (1) · Georgia (1) · Hungary (1) · Italy (1) · Lebanon (1) · Poland (1) · Russia (1) · Serbia (1) · Spain (1) · Ukraine (1) · United States (1)
Emily S. Riser, MD (1) · Tracy L Goeken, M.D. (1)